Want to join the conversation?
On Jan. 8, 2016, $MYL entered into an agreement with Momenta Pharmaceuticals to develop, manufacture & commercialize up to 6 of Momenta's current biosimilar candidates. $MYL paid an up-front cash payment of $45MM to Momenta. The company & Momenta will jointly be responsible for product development and will equally share product costs and profits.
Can you imagine a food store with no cash registers? Well, it is coming true soon thanks to $AMZN. The company is opening its new grocery store in Seattle and it has no cash registers. AI takes over!
$AVGO reports 4Q earnings today. I am wondering what to expect.
$SHLD seems to be rolling down the curve, it has been reporting net loss for the past many quarters. The Company Board seems to be doing nothing to stem this trend.